Skip to main content

Advertisement

SpringerLink
Log in

Oxidative Stress-Induced Response of Some Endogenous Antioxidants in Schizophrenia

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Reactive oxygen species (ROS) formed in various metabolic reactions cause unlimited damage by attacking and oxidizing the macromolecules. An arsenal of antioxidant substances neutralizes these ROS at various sites of their metabolic cascade, and if disequilibrium exists between the pro and antioxidant system, oxidative stress persists. The present study was undertaken in schizophrenia, to highlight the response and role of some endogenous antioxidants viz. reduced glutathione (GSH), bilirubin, total proteins, albumin and uric acid in scavenging the ROS. The effect of severity of disease, age factor, and substance abuse was also studied. In all, 50 schizophrenics and 50 age and sex-matched controls were enrolled in the present study. Fasting blood samples were drawn for estimating malondialdehyde (MDA), GSH, bilirubin, total proteins, albumin and uric acid in both the groups. The results were statistically analyzed by Z-test and correlated using correlation coefficient (r). The study shows reduction in MDA levels and decline in the level of endogenous antioxidants, but within the normal range. Chronic schizophrenics were at a higher risk of oxidative stress and age and substance abuse seems to worsen the situation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp. 1995;61:1–31.

    PubMed  CAS  Google Scholar 

  2. Leibovitz BE, Siegel BV. Aspects of free radical reactions in biological systems: aging. J Gerontol. 1980;35(1):45–56.

    PubMed  CAS  Google Scholar 

  3. Singh RP, Sharad S, Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. JIACM. 2004;5(3):218–25.

    Google Scholar 

  4. Gassen M, Youdim MB. Free radical scavengers: chemical concepts and clinical relevance. J Neural Trans Suppl. 1999;56:193–210.

    CAS  Google Scholar 

  5. Ogawa N. Free radicals and neural cell damage. Rivisho Shinkeigaku. 1994;34:1266–8.

    CAS  Google Scholar 

  6. Lohr JB. Oxygen radicals and neuropsychiatric illnesses. Arch Gen Psychiatry. 1991;48:1097–106.

    Article  PubMed  CAS  Google Scholar 

  7. Kaplan SI, Sadock BJ. Schizophrenia. In: Comprehensive textbook of psychiatry. 6th ed. Baltimore: Vol 1, Williams and Wilkins; 1989. p. 699–815.

  8. Sharma S, Sharma S. Biochemical evaluation of lipid and oxidative stress status in relation to high fat-high antioxidant diets. Ind J Expl Biol. 2001;39(11):1180–3.

    CAS  Google Scholar 

  9. Reddy R, Yao JK. Schizophrenia: role of oxidative stress and essential fatty acids. In: Antioxidants in human health. New York: CAB International; 1999. p. 351–66.

  10. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biopsy. 1990;280(1):1–8.

    Article  CAS  Google Scholar 

  11. Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91:31S–8S. Review.

    Article  PubMed  CAS  Google Scholar 

  12. Marshall WJ, Bangert SK. Free radicals. In: Clinical biochemistry: metabolic and clinical aspects. London: Churchill Livingstone; 1995. p. 765–77.

  13. Vendemiale G, Grattagliano I, Altomare E. An update on the role of free radicals and antioxidant defense in human disease. Ind J Clin Lab Res. 1999;29:49–55.

    Article  CAS  Google Scholar 

  14. Dadheech G, Mishra S, Gautam S, Sharma P. Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Ind J Clin Biochem. 2006;21:34–8.

    Article  CAS  Google Scholar 

  15. Dadheech G, Mishra S, Gautam S, Sharma P. Evaluation of antioxidant deficit in schizophrenia. Ind J Psychiatry. 2008;50:16–20.

    Article  Google Scholar 

  16. Beutler E. Red cell metabolism. In: A manual of biochemical methods. New York: Grune and Stratton; 1971. p. 103–105.

  17. Stock J, Dormandy TL. The autoxidation of human and red cell lipids induced by hydrogen peroxide. Br J Hematol. 1971;20:95–111.

    Article  Google Scholar 

  18. Halliwell B. The chemistry of free radicals. Toxicol Ind Health. 1993;9(1-2):1–21. Review.

    PubMed  CAS  Google Scholar 

  19. Meister A. Mini review: glutathione–ascorbic acid antioxidant system in animals. J Biol Chem. 1994;269:9397–400.

    PubMed  CAS  Google Scholar 

  20. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145–51.

    Article  PubMed  CAS  Google Scholar 

  21. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant and radical causing aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78(11):6858–62.

    Article  PubMed  CAS  Google Scholar 

  22. Halliwell B. Free radicals, antioxidants and human diseases: curiosity, cause or consequence? Lancet. 1994;344:721–4.

    Article  PubMed  CAS  Google Scholar 

  23. Stohs SJ. The role of free radicals in toxicity and disease. J Basic Physiol Pharmacol. 1995;6:205–28.

    Article  CAS  Google Scholar 

  24. Vilkov GA, Kiroi RI, Stepnina EG, Smimova OV, Kovalenko VA, Trapezontseva RA. Lipid peroxidation and microviscosity of erythrocyte membranes in patients with schizophrenia. Zn Nevropatol Psikhiatr. 1991;91:45–7.

    CAS  Google Scholar 

  25. Drewa G, Bala G, Gzerwionka Szaflarska M, Szaflarska-Szazepanik S. Oxyradicals and other oxidants: their generation, specificity and reactivity in biological systems. Med Sci Monit. 1996;2(5):681–7.

    Google Scholar 

  26. Hughes JR, Hatsukami DK, Mitchell JE, et al. Prevalence of smoking among psychiatric patients. Am J Psychiatry. 1986;143:993–7.

    PubMed  CAS  Google Scholar 

  27. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull. 1998;24(3):443–55.

    Article  PubMed  CAS  Google Scholar 

  28. Schultz JB, Lindenan J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem. 2000;267(16):4904–11.

    Article  Google Scholar 

  29. Grima G, Benz B, Parpura V, Cuenod M, Do KQ. Dopamine-induced stress in neurons with glutathione deficiency implication for schizophrenia. Schizophr Res. 2003;62(3):213–24.

    Article  PubMed  Google Scholar 

  30. Kidd PM. Natural antioxidants and first line of defense. In: Kidd PM, Huber W, editors. Living with the AIDS virus: a strategy for long-term survival. California: PMK Biomedical-Nutritional Consulting; 1991. p. 115–142.

  31. Sohal RS, Weindruch R. Oxidative stress, caloric restriction and aging. Science. 1996;273:59–63.

    Article  PubMed  CAS  Google Scholar 

  32. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA. 1987;84(16):5918–22.

    Article  PubMed  CAS  Google Scholar 

  33. Muller N, Schiller P, Ackenheil M. Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry. 1991;24(6):225–8.

    Article  PubMed  CAS  Google Scholar 

  34. Dani C, Martelli E, Bertini G, Pezzati M, Filippi L, Rossetti M, Rizzuti G, Rubattelli FF. Plasma bilirubin level and oxidative stress in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003;88(2):F. 119–23.

    Article  Google Scholar 

  35. Hidalgo FJ, Zamora R, Dillard CJ, Tappel AL. Can serum bilirubin be an index of invivo oxidative stress? Med Hypotheses. 1990;33(3):207–11.

    Article  PubMed  CAS  Google Scholar 

  36. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischaemic heart disease in middle aged British men. Clin Chem. 1995;41(10):1504–8.

    PubMed  CAS  Google Scholar 

  37. Frei B, Stocker R, Ames BN. Antioxidant defense and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 1988;85(24):9748–52.

    Article  PubMed  CAS  Google Scholar 

  38. Huang TL. Decreased serum albumin levels in Taiwanese patients with schizophrenia. Psychiatry Clin Neurosci. 2002;56(6):627–30.

    Article  PubMed  CAS  Google Scholar 

  39. Rodionov RN. Urate as an endogenous antioxidant. Free Radic Biol Med. 2003; 77(222):1–11.

    Google Scholar 

  40. Yao JK, Reddy R, Van Kammen DP. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr Res. 1998;32(1):1–8.

    Article  PubMed  CAS  Google Scholar 

  41. Yao JK, Reddy R, Van Kammen DP. Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res. 1988;80(1):29–39.

    Article  Google Scholar 

  42. Uma DP, Devipriya D, Chinnaswamy P. Age and gender related changes in total antioxidant response and oxidative stress in patients with schizophrenia. J Clin Diagn Res. 2008;14(2):627–33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, NIMS Medical College, Shobha Nagar, Jaipur, Rajasthan

    Gora Dadheech

  2. Department of Biochemistry, Govt. Medical College, Kota, Rajasthan

    Praveen Sharma

  3. Department of Psychiatry, NIMS Medical College, Shobha Nagar, Jaipur, Rajasthan

    Shiv Gautam

Authors
  1. Gora Dadheech
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Praveen Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shiv Gautam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Praveen Sharma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dadheech, G., Sharma, P. & Gautam, S. Oxidative Stress-Induced Response of Some Endogenous Antioxidants in Schizophrenia. Ind J Clin Biochem 27, 278–283 (2012). https://doi.org/10.1007/s12291-012-0193-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-012-0193-z

Keywords

Search

Navigation